BioAtla, Inc. (BCAB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-164.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $300.0K | — | — | — |
| Operating Income | -$59.30M | -$73.94M | -$129.69M | -$108.14M | -$96.44M | -$30.10M | -$28.27M | — |
| Net Income | -$59.61M | -$69.78M | -$123.46M | -$106.48M | -$95.40M | -$35.85M | -$29.86M | — |
| EPS (Diluted) | $-1.01 | $-1.44 | $-2.58 | $-2.74 | $-2.76 | — | — | — |
| Total Assets | $13.83M | $52.42M | $119.66M | $225.74M | $254.42M | $244.94M | — | — |
| Total Liabilities | $50.02M | $38.16M | $48.99M | $45.40M | $43.60M | $34.96M | — | — |
| Shareholders' Equity | $36.19M | $14.27M | $70.67M | $180.34M | $210.82M | $209.97M | -$56.01M | -$28.45M |
| Cash & Equivalents | $7.12M | $49.05M | $111.47M | $215.51M | $244.98M | $238.60M | $3.70M | $10.86M |
| Operating Cash Flow | -$48.20M | -$71.94M | -$104.02M | -$90.42M | -$62.21M | -$36.33M | -$9.64M | — |
| Shares Outstanding | 63.46M | 58.10M | 48.08M | 46.34M | 35.80M | 32.17M | — | — |